GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Themis Biosyn Ltd (BOM:506879) » Definitions » Cyclically Adjusted PS Ratio

Gujarat Themis Biosyn (BOM:506879) Cyclically Adjusted PS Ratio : 32.05 (As of Jun. 04, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Gujarat Themis Biosyn Cyclically Adjusted PS Ratio?

As of today (2025-06-04), Gujarat Themis Biosyn's current share price is ₹306.40. Gujarat Themis Biosyn's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₹9.56. Gujarat Themis Biosyn's Cyclically Adjusted PS Ratio for today is 32.05.

The historical rank and industry rank for Gujarat Themis Biosyn's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:506879' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.68   Med: 14.23   Max: 41.93
Current: 32.37

During the past years, Gujarat Themis Biosyn's highest Cyclically Adjusted PS Ratio was 41.93. The lowest was 5.68. And the median was 14.23.

BOM:506879's Cyclically Adjusted PS Ratio is ranked worse than
98.78% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.13 vs BOM:506879: 32.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Gujarat Themis Biosyn's adjusted revenue per share data for the three months ended in Mar. 2025 was ₹3.491. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹9.56 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Gujarat Themis Biosyn Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Gujarat Themis Biosyn's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Themis Biosyn Cyclically Adjusted PS Ratio Chart

Gujarat Themis Biosyn Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.60 9.41 13.08 31.45 29.45

Gujarat Themis Biosyn Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.45 35.58 40.46 32.59 29.45

Competitive Comparison of Gujarat Themis Biosyn's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Themis Biosyn's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Themis Biosyn's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Themis Biosyn's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Gujarat Themis Biosyn's Cyclically Adjusted PS Ratio falls into.


;
;

Gujarat Themis Biosyn Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Gujarat Themis Biosyn's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=306.40/9.56
=32.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Themis Biosyn's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Gujarat Themis Biosyn's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.491/157.5517*157.5517
=3.491

Current CPI (Mar. 2025) = 157.5517.

Gujarat Themis Biosyn Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.755 99.841 1.191
201509 0.759 101.753 1.175
201512 0.724 102.901 1.109
201603 0.760 102.518 1.168
201606 0.771 105.961 1.146
201609 0.008 105.961 0.012
201612 0.780 105.196 1.168
201703 0.955 105.196 1.430
201706 0.871 107.109 1.281
201709 0.873 109.021 1.262
201712 0.900 109.404 1.296
201803 0.919 109.786 1.319
201806 0.949 111.317 1.343
201809 0.964 115.142 1.319
201812 0.905 115.142 1.238
201903 0.936 118.202 1.248
201906 1.072 120.880 1.397
201909 1.507 123.175 1.928
201912 2.808 126.235 3.505
202003 2.402 124.705 3.035
202006 1.439 127.000 1.785
202009 2.496 130.118 3.022
202012 2.239 130.889 2.695
202103 2.124 131.771 2.540
202106 2.976 134.084 3.497
202109 3.215 135.847 3.729
202112 1.707 138.161 1.947
202203 2.578 138.822 2.926
202206 4.124 142.347 4.564
202209 4.377 144.661 4.767
202212 2.585 145.763 2.794
202303 2.509 146.865 2.692
202306 4.552 150.280 4.772
202309 3.625 151.492 3.770
202312 3.546 152.924 3.653
202403 3.862 153.035 3.976
202406 3.559 155.789 3.599
202409 3.187 157.882 3.180
202412 3.625 158.323 3.607
202503 3.491 157.552 3.491

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Gujarat Themis Biosyn  (BOM:506879) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Gujarat Themis Biosyn Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Gujarat Themis Biosyn's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Gujarat Themis Biosyn Business Description

Traded in Other Exchanges
Address
S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.

Gujarat Themis Biosyn Headlines

No Headlines